PhillipCapital analyst Tay Wee Kuang has maintained his “accumulate” call on Hyphens Pharma with a reduced target price of 36.5 cents from 49.5 cents

PhillipCapital cuts Hyphens Pharma's TP on 9M earnings falling below estimates

SINGAPORE (May 15): Net profit of catalist-listed pharmaceutical distributor Hyphens Pharma soared 48.6% to $2.1 million in 1Q20 ended March, from the $1.4 million logged a year

Hyphens Pharma weathers Covid-19 storm with increases in all segments

SINGAPORE (July 10): Hyphens Pharma International has launched its so-called "next generation" Ceradan

Hyphens Pharma launches Ceradan Advanced

Ceradan

ESR-LOGOS REIT reports 2HFY2022 DPU of 1.54 cents, up by 7.5% y-o-y

Analysts see 'resilient' results for MLT's 3QFY2023 although Citi sees 'negative' share impact on forex weakness

How LREIT became the first net-zero S-REIT

Pushing for a passwordless future

Maximising the ROI of low-code development

Chinese search giant Baidu to launch ChatGPT-style bot

US stocks are poised to hit new lows this year, survey of investors shows

Malaysia PM Anwar tells Goldman to pay up on 1MDB settlement

Anwar vows gradual debt reduction to ensure stability

Timekeepers for the new year

See the latest from Fendi, Chaumet and more

The art of Kappo

The green future of industrial sustainability

Future of finance: How DeFi could help traditional finance

China recalibrates its policies: What does that mean?

RHB Singapore offers exclusive 4.28% p.a. fixed deposit rate at refreshed Cecil branch

Grab receives a more bullish call from Aletheia Capital; takeover of GoTo reiterated

Capital World to sell most of its space at its Johor mall to Mustafa for RM368 mil

Phillip Securities keeps an eye on 'disinflation' and China reopening exposure in picking its 10 stocks

Mercatus divests 50% indirect stake in Nex for $652.5 mil